2013国际抗癫痫联合会抗癫痫药用指南
2022-04-11 00:23:44 来源: 三亚癫痫医院 咨询医生
hepurposeofthisreportwastoupdatethe2006InternationalLeagueAgainstEpilepsy(ILAE)reportandidentifythelevelofevidenceforlong-termefficacyoreffectivenessforantiepilepticdrugs(AEDs)asinitialmonotherapyforpatientswithnewlydiagnosedoruntreatedepilepsy.AllapplicablearticlesfromJuly2005untilMarch2012wereidentified,evaluated,andcombinedwiththepreviousysis(Glauseretal.,2006)toprovideacomprehensiveupdate.
Thepriorysismethodologywasutilizedwiththreemodifications:(1)thedetectablenoninferiorityboundaryapproachwasdroppedandbothfailedsuperioritystudiesandprespecifiednoninferioritystudieswereyzedusinganoninferiorityapproach,(2)thedefinitionofanadequatecomparatorwasclarifiedandnowincludesanabsoluteminimumpointestimateforefficacy/effectiveness,and(3)therelationshiptablebetweenclinicaltrialratings,levelofevidence,andconclusionsnolongerincludesarecommendationcolumntoreinforcethatthisreviewofefficacy/evidenceforspecificseizuretypesdoesnotimplytreatmentrecommendations.
Thisevidencereviewcontainsoneclarification:ThecommissionhasdeterminedthatclassIsuperioritystudiescanbedesignedtodetectuptoa20?solute(ratherthanrelative)differenceinthepointestimateofefficacy/effectivenessbetweenstudytreatmentandcomparatorusinganintent-to-treatysis.SinceJuly,2005,threeclassIrandomizedcontrolledtrials(RCT)and11classIIIRCTshebeenpublished.Thecombinedysis(1940-2012)nowincludesatotalof64RCTs(7withclassIevidence,2withclassIIevidence)and11meta-yses.
Newefficacy/effectivenessfindingsincludethefollowing:levetiracetamandzonisamidehelevelAevidenceinswithpartialonsetseizuresandbothethosuximideandvalproicacidhelevelAevidenceinchildrenwithchildhoodabsenceepilepsy.
Therearenomajorchangesinthelevelofevidenceforanyothersubgroup.LevetiracetamandzonisamidejoincarbamazepineandphenytoinwithlevelAefficacy/effectivenessevidenceasinitialmonotherapyforswithpartialonsetseizures.AlthoughethosuximideandvalproicacidnowhelevelAefficacy/effectivenessevidenceasinitialmonotherapyforchildrenwithabsenceseizures,therecontinuestobeanalarminglackofwelldesigned,properlyconductedepilepsyRCTsforpatientswithgeneralizedseizures/epilepsiesandinchildreningeneral.
Thesefindingsreinforcetheneedformulticenter,multinationaleffortstodesign,conduct,andyzefutureclinicallyrelevantadequatelydesignedRCTs.Whenselectingapatient'sAED,allrelevantvariablesandnotjustefficacyandeffectivenessshouldbeconsidered.
查看信源地址
编辑:jiang上一页:预测癫痫患者再入院风险
下一页:癫痫治疗障碍仍难以克服
- 2022-04-132016AAN:神经专家发表了有前途的专业见解
- 2022-04-12癫痫发作对中风患者静脉溶栓的长期转移有效
- 2022-04-11癫痫治疗障碍仍难以克服
- 2022-04-112013国际抗癫痫联合会抗癫痫药用指南
- 2022-04-07预测癫痫患者再入院风险
- 2022-04-05【用药问答】癫痫发作和局限性发作的首选治疗是什么?
- 癫痫发作对中风患者静脉溶栓的长期转移有效
- 癫痫治疗障碍仍难以克服
- 2013国际抗癫痫联合会抗癫痫药用指南
- 预测癫痫患者再入院风险
- 【用药问答】癫痫发作和局限性发作的首选治疗是什么?
- FDA批准Aptiom用于治疗患者癫痫发作
- 上海率先探索异地就医门诊费直接结算
- 治疗癫痫 治疗癫痫偏方大全
- 月经性癫痫患者妊娠期癫痫控制更好
- 癫痫定位新方法:无框架立体定向脑电图技术
- 美国神经病学协会的新指南帮助医生HIV癫痫药物更适合患者
- 泡温泉时不能忽视的事情
- 【用药情报站】临床应用应听取各种药种药物禁忌证?
- UCB的Vimpat癫痫新适应症在美国获批
- Circ Ep:左室肥厚高血压患者新发房颤增加SCD风险
- 综述:癫痫持续状态诊治最新进展
- 抗癫痫药物预防新发癫痫:任重而道远
- PLoS ONE:新的合成蛋白能快速激活免疫系统抵抗流感
- 不注意这些问题,吃多少药都没用!
- 北京哪家癫痫医院排名好,成本低
- 心理百科:春节期间小心疾病
- 癫痫患者手术评估新型工具
- 世界癫痫日 | 科学防治 标准诊疗 告别癫痫
- 手术学习:颅内脊索瘤内镜下三脑室入路治疗
- 特发性癫痫大发作药物治疗的首选
- 英国竞争监管机构指控辉瑞癫痫药品价格过高
- 引起癫痫病发作的因素所有哪些
- 应该怎么样管控癫痫病
- 花季不良少年突发癫痫 竟是脑中住着一位「君」
- 癫痫病诊断的依据是什么
- 癫痫病小发作征状 这些征状就是癫痫小发作
- 引起癫痫疾病的非主流病因有哪些
- 严重癫痫病要花多少钱
- 癫痫病的症状及疗法
- 开刀能治癫痫病吗
- 抑郁症可以治愈吗?抑郁症治疗新突破:基于病因诊断基础上的精准治疗
- 癫痫病必须怎样来进行诊断
- 癫痫病症状 怎样护理人员癫痫病人
- 引起睡眠普遍性癫痫的病因都是什么
- NMPA:2021年获选批准上市的创新药